As Merck prepares to release its fourth-quarter results, investors are watching to see if the pharmaceutical leader can maintain its track record of exceeding expectations amid a slowing growth outlook.
A private gauge of China's manufacturing activity edged higher in January, defying expectations of a slowdown, as export-oriented firms outperformed. The reading contrasts with weaker official data, highlighting a two-speed industrial sector amid persistent domestic headwinds.
Prudential Financial (NYSE: PRU) is scheduled to release its fourth-quarter earnings after the market closes on Tuesday, with investors closely watching for signs of resilience in the insurance sector.
Electrical systems specialist Powell Industries (NYSE:POWL) prepares to release its fourth-quarter results after Tuesday's market close, with investors weighing solid recent performance against a projected slowdown in revenue growth.
Benchmark Electronics (NYSE:BHE) is set to report Q4 earnings after Tuesday's market close, with analysts forecasting a return to revenue growth. The electronics manufacturing services provider enters the report on a strong note, having outperformed expectations last quarter.
As Transcat prepares to release its quarterly results, investors are weighing its strong revenue growth trajectory against a history of earnings volatility. The industrial distributor's performance will be a key test amid mixed signals from the sector.
A federal class-action lawsuit alleges Blue Owl Capital, a major player in the $1.7 trillion private credit market, restricted investor withdrawals amid mounting redemptions, testing Wall Street's promise of 'democratized' alternative investments for Main Street.
As Ingredion prepares to release its fourth-quarter results, investors are weighing whether the company can stabilize after a disappointing prior quarter. The broader staples sector's recent strength offers a cautiously optimistic backdrop.
As J&J Snack Foods prepares to release its quarterly results, investors are weighing stable analyst expectations against a backdrop of mixed performance in the shelf-stable food sector.
Graphic Packaging Holding (NYSE:GPK) is scheduled to release its fourth-quarter earnings before Tuesday's market open. Analysts project a year-over-year revenue decline, while investor sentiment in the industrials sector shows cautious optimism.
A new $45 fee for air travelers lacking a REAL ID or other approved identification is now in effect. The TSA's ConfirmID program aims to shift processing costs to non-compliant passengers, urging advance online payment to avoid airport delays.
Katlyn Lyon Montgomery was found strangled in her Bedford County apartment days after ending a relationship with a man who had fabricated his entire life. Prosecutors allege he scaled her balcony dressed as a 'ninja' to carry out the attack.
Los Angeles skincare entrepreneur Dawn DaLuise spent months believing a business competitor was terrorizing her, only to discover the real perpetrators were two close friends—a revelation detailed in a new true-crime documentary.
A five-year analysis of Singapore Shipping Corporation reveals flat returns on capital, raising questions about its growth trajectory in a competitive maritime sector.
A significant purchase of the VictoryShares USAA Core Short-Term Bond ETF (USTB) by wealth manager Merit Financial Group highlights institutional interest in short-duration, income-focused strategies amid market uncertainty.
Oracle's shares have tumbled roughly 36% in three months, sparking debate over whether the sell-off presents a deep-value entry point or reflects justified skepticism about the company's ability to monetize its massive AI ambitions.
Shares of Spanish residential developer Neinor Homes have surged nearly 30% over the past year, prompting investors to question whether the rally has pushed the stock beyond its fair value. A deep dive into key valuation metrics suggests caution may be warranted.
After a relatively subdued 2025, Wall Street's projections for Nvidia's revenue growth remain robust. Analysts are debating whether the chipmaker's current valuation sets the stage for a significant rebound or a period of consolidation.
Glaukos Corporation's iDose TR glaucoma therapy receives a key FDA labeling update, permitting repeat administration. While the news bolsters the company's growth narrative, analysts are divided on whether its current stock price already reflects future potential amid rich valuation metrics.
With shares of the global sustainability leader up nearly 7x over three years, investors are grappling with a critical question: has the market run too far ahead of fundamentals? A deep dive into valuation metrics suggests caution may be warranted.
